Podcasts about Crest

Stephanie sits down with Mindy Coolman, race director of Crown of the Crest and a key member of GOATZ (Greater Omaha Area Trail Runners), to explore what goes into creating memorable trail running experiences. From local 5Ks to challenging 100-mile events, Mindy shares the story behind GOATZ, the evolution of their race lineup, and the passion that fuels Nebraska's growing trail running community.The conversation dives into the often-unseen side of race directing: recruiting volunteers, designing runner experiences, balancing logistics, and fostering the welcoming atmosphere that keeps athletes coming back year after year. Stephanie reflects on her recent experience at Crown of the Crest, while Mindy offers insight into what makes a race feel special long after runners cross the finish line.Along the way, they swap stories about ultra-running culture, race-day fueling, recovery, injuries, and the lessons that come from spending countless hours on the trail. From ambitious future race goals to the surprising appeal of sweaty pocket Oreos, this episode is a fun and honest look at the people, challenges, and community that make endurance sports so rewarding.Be sure to subscribe to the podcast wherever you listen, and we always appreciate you leaving a good rate and review. Join the Facebook Group and follow us on Instagram and check out our website for the more episodes, posts and merchandise coming soon.Have a topic you'd like to hear discussed in depth, or a guest you'd like to nominate? Email us at info@happyendingstc.org

Welcome to the Bob Elliott show where we will educate and have fun regarding various Tucson, Southern Arizona, State of Arizona, and national events. We will not be about politics or religion. We will emphasize leaders in our community and what they do, why they do it and how they do it.  People Make the Job; the Job does not make the person. There are a lot of organizations in town, great organizations, that provide services for our community. Who are they? What do they do? Are they eligible to receive an Arizona state tax credit? That is who we are, and that is what we will do, on a weekly basis. Show Guest: Corey Williams, former UA basketball player, ESPN TV broadcaster, Crest insurance executive.  Guest background:  Please welcome to the show Corey Williams.    Oral histories. It is an opportunity for people to give their story in their words without it being edited. I would like to start today with where you were born. Tell us about your upbringing. Any siblings? Your parents, etc.

Buteo, Aurek & Cart interrogate a prisoner at Chill Stone Keep. Enid reconnects with her familiar, Keen.DM-DuganPlayers-Audi, Cody, Kent & Priscilla Music by- Suno

This week on ARG Presents, no more mister NICE GUY! We're playing Games Where YOU Are The Villain...shouldn't be much of a stretch for THE BRENT! Join DEM BADS as we tackle Demon's Crest and DEAD By Daylight! Insert evil laugh here!

In this episode of the Neurocritical Care Society Podcast Masterclass series, hosts Stephan Mayer, MD, FCCM, FNCS, and Jon Rosenberg, MD, are joined by Seemant Chaturvedi, MD, professor of neurology and director of the Stroke Division at the University of Maryland, for an in-depth discussion on carotid disease, stroke prevention and the role of revascularization in clinical practice. The episode explores the historical impact of NASCET, key findings from the CREST-2 trial and the role of intensive medical management for patients with asymptomatic carotid stenosis. Dr. Chaturvedi also shares practical guidance for neurointensivists caring for patients with symptomatic carotid disease, including intervention timing, risk stratification and emerging diagnostic tools such as MRI plaque imaging and TCD microemboli monitoring. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Send us Fan MailRolling in the Netherdeep has evolved into Few and Far Between!!Few And Far Between Ep 160Star of the Winter's Crest Part 2After defeating the denizens of the undead dinner party, the Few must track down several nexuses of evil within Sifter Manor.Thanks to Critical Role for helping the community build worlds of adventure!Connect with us via our Linktree!Ron Murphy – DM, @ron88keysRBDMLaphus Prismawing - Jaiden Ramirez, @ffoxtrotXIVOrgoth Skullcrusher - Bill Roper, @billfreakinroperNorth Star Maedrick - Jaime R. Bishop, @steelcladvicarFollow us on Twitter at @SeveredSonsDnD or on Instagram!Join our Discord! Join our Patreon!Now, you can support us through the Buzzsprout website too!Give us a review on Apple Podcasts, Podchaser, Spotify,  GoodPods or on our Twitter page and we'll read it on the air.   Support the show

Support my work on Patreon- https://patreon.com/realdavejackson Discord, Socials and more- https://linktr.ee/talesfromthebacklog Join Dave and special guest Claire as they deep dive Fire Emblem: Three Houses (Intelligent Systems, Kou Shibusawa, Nintendo, 2019). They discuss the life sim and battle elements, how they tie together to make you fear permadeath even more, the four playthroughs, and much more. As always, no spoilers for a while! Guest info: Claire (she/her/any) Check out Date With Us podcast https://www.datewith.us Check out Claire on Twitch https://www.twitch.tv/claireafterall Get a sick wrestling belt https://www.trophysmack.com/ TIMESTAMPS 0:00 Title Card 0:21 Introductions 5:03 Our Histories with Fire Emblem 7:35 Top-Level Thoughts 14:36 Story Setup and Choosing Your House 23:49 Life Sim Elements and How To Spend Time 30:00 Teaching and Character Building 36:11 Relationship/Support Mechanics 40:25 Relationship and Dating Elements 55:36 Combat and Permadeath 1:05:18 Combat Basics 1:15:00 What's New in the DLC? 1:19:56 Soundtrack 1:26:10 Visual Design and Art 1:31:57 Who Should Play? 1:38:17 Date With Us and Claire's Streaming 1:44:36 Spoiler Wall and Patron Thank-Yous 1:46:26 Spoilers- Story Discussion 2:29:39 Spoilers- MVPs and Results Music used in the episode: The Crest of Flames (Yuka Tsujiyoko) Fódlan Winds (Takeru Kanazaki) Life at Garreg Mach Monastery (Takeru Kanazaki) Tearing Through Heaven (Hiroki Morishita) Tempest of Seasons (Rei Kondoh) A Guide for the Future (Takeru Kanazaki) A New Dawn (Takeru Kanazaki, Rei Kondoh) The Land Beloved by the Goddess (Takeru Kanazaki) Cover art by Jack Allen- find him at https://linktr.ee/JackAllenCaricatures

This week on ARG Presents, no more mister NICE GUY! We're playing Games Where YOU Are The Villain...shouldn't be much of a stretch for THE BRENT! Join DEM BADS as we tackle Demon's Crest and DEAD By Daylight! Insert evil laugh here!

Enid reunites with her familiar, Keen. Cart overcomes a very unusual dream and memories of her past. Buteo and Aurek assist in an interrogation.DM- DuganPlayers- Audi, Priscilla, Cody & KentOpening and Closing Music by: Suno

In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Cheryl Bushnell, MD, MHS, who served as the guest editor of the June 2026 Cerebrovascular Disease issue. They provide a preview of the issue, which publishes on June 3, 2026. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Bushnell is a Professor of Neurology and Director of the Center for Transformative Stroke Care at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @CBushnellMD  Full episode transcript available here Dr Jones: One of the core tenets of our field is that we learn neurology one stroke at a time. But what do we have to learn about preventing them altogether? The science of stroke prevention, acute treatment, and recovery are evolving rapidly, and it's hard to keep up. Today, we're speaking with Dr. Cheryl Bushnell, guest editor of our latest Continuum issue on Cerebrovascular Disease, to discuss these topics and much more.  Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast.  Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr. Cheryl Bushnell, who is Continuum's guest editor for our latest issue on Cerebrovascular Disease. Dr. Bushnell is a professor of neurology and the director of the Center for Transformative Stroke Care at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where she specializes in the care of stroke patients and their social and functional determinants of recovery and health, and is an internationally recognized expert on those topics. Dr. Bushnell, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners?  Dr Bushnell: Absolutely. Thank you for the invitation. It's really an honor to be here. So, as you mentioned, I am the director of the Center for Transformative Stroke Care at Wake Forest. It's a really fun transition for me to be involved with different care models for stroke, and I think a lot of the Continuum topics are directly relevant to some of the things that I'm doing now as an administrator and sort of a facilitator of new research. So, thanks again for having me.  Dr Jones: Yeah, and, and you have a wonderful perspective, and we're gonna pull that out today in our interview questions, and I'm looking forward to sharing that with our listeners. But before we get to the questions, we're gonna start off today's podcast with another Continuum Audio trivia question for our listeners. Anticoagulation has played a critical role in secondary ischemic stroke prevention for a long time now. While direct oral anticoagulants have taken on a greater role in the treatment of prevention of stroke, there are still some use cases for vitamin K antagonists like warfarin. The trivia question for our listeners is this: How was warfarin discovered, and how did it get its name? Stick around and we'll share the answer to that question toward the end of our interview today. So, Dr. Bushnell, let's get right to it. You alluded to your various roles, and your leadership in the field has been exemplary. The interventions for acute ischemic stroke have really exploded over the last decade or so, and they get a lot of attention and discussion, but prevention and recovery are just as important in the care of these patients. Tell us a little more about how you approached this issue, about the article topics you chose, etc.  Dr Bushnell: Well, once I was chosen to lead the guest editorship, I wanted to come up with a group of topics that were maybe a little bit different from previous issues. So, I kind of looked at the previous issues and saw, as you said, an emphasis on acute stroke, and that's really important because it has been evolving. But my thought was, how about what happens to patients after they get the intervention and they're discharged home? And because a lot of trainees may not get to see these patients ever again, or it's months before they might see them, or if they're readmitted, which is what we don't want to see, but that certainly is a lot of the exposure is in the inpatient setting. So, I thought I would kind of transport the education into the outpatient and transitional setting, as well as prevention, not only secondary, but primary prevention, with an emphasis on brain health. Some of the populations that may not get as much attention. So, sex differences, stroke in women, pregnancy, the transitions of care, and also the emphasis on holistic view of patients and their challenges, which includes the non-medical factors that drive health, otherwise known as social determinants of health.  Dr Jones: I appreciate that perspective, and obviously th-this is an area of your deep expertise, and it's great to have an issue that really digs into some of those topics a little more deeply. As an educator, I'm really glad you mentioned that about the trainee's perspective. You know, especially junior neurology trainees that are in the hospital all the time. They're seeing patients in the middle of a cerebrovascular catastrophe. But there's a long tail of recovery, right? And they'll get to see that in continuity clinic, but it's a good message to share from an evidence and, um, experiential perspective in the issue. So, appreciate that perspective. You've just read all these articles and edited them. Was there anything that you ran across that was a surprise to you?  Dr Bushnell: Well, I personally chose a lot of the authors based on my knowledge of their work. So, I wouldn't say that it was completely surprising, but I do think that I was just genuinely impressed with the quality of the writing and the synthesis of information. I just was incredibly proud of the work that these co-authors have put together. I'd say that that was-- it wasn't surprising so much as just a sense of pride that I had with the product that's coming out. But of course, there have been some new trials that had to be incorporated at the last minute, some of which were presented at the International Stroke Conference just a few weeks ago.  Dr Jones: Yeah. We try to be as up-to-date as we can, and I will completely agree with you. We have some really good writers in our field, and it's really just a pleasure when you read an article that's by an expert, and it's a joy to read. I can tell you it's one of the best parts of this job, and you get to learn a lot. I think one of the more challenging scenarios that I hear about from colleagues in recent years has been optimal management of patients with asymptomatic extracranial atherosclerosis. The pivotal trials that inform how we manage those patients were from a long time ago, decades ago, predating a lot of the more intensive medical management tools that we have today. In that scenario, Dr. Bushnell, what's the latest on that, and what should our listeners know?  Dr Bushnell: Well, obviously, the CREST 2 trial has been long awaited. It's been going on for over ten years, I believe. Of course, it's, uh, two different trials all in one, the carotid stenting and angioplasty versus intensive medical management. And of course, each of the carotid vascularization arms of the trial also had intensive medical management. And then the other trial is the carotid endarterectomy as the form of revascularization. And it interestingly did not show any benefit of carotid endarterectomy compared to intensive medical management. But of course, the somewhat surprising result was that carotid angioplasty and stenting truly was superior, although it was a small number of events in the trial overall. But that stenting plus intensive medical management was somewhat better than intensive medical management alone. And I think stenting has come a long way in terms of safety, and so I think that's been part of the evolution of the field. I do wanna say that I'm a huge fan of the intensive medical management, and I think that what the protocol does in terms of blood pressure management, cholesterol management is very much above and beyond what's done in private practice even. And the health coaching for all the other things related to diabetes and weight loss and smoking cessation and physical activity, that is what we need to be doing to actually decrease the risk of stroke, and I think that it's very effective. I can't say enough about the design of the study for that reason, that everyone gets the intensive medical management, and then you just layer on the type of revascularization on top of it. So, I wouldn't have been surprised if this was a completely negative trial overall. They just happened to have some better outcomes in the stenting arm.  Dr Jones: I recall a few years ago when the series of endovascular therapy trials for acute stroke came out, and I think there was a, a period of time where the field had to adapt to that. I wonder what you think about with the CREST 2 findings on stenting. I mean, is that gonna be a big change? Because obviously atherosclerosis is highly prevalent. Is that gonna be a big change? Is the field ready for that? How much adjustment do we have in store?  Dr Bushnell: I'm not sure it's gonna be a really big change. If you read the editorial that accompanied the trial in the New England Journal, just a few patients in either direction would have changed the outcome. I kind of look at it as an absolute difference that's relatively small. So, I'm not sure that it will have a huge impact on the field. I do think that the specialists who insert the stents may have some differences of opinion of who should be stented and who shouldn't. Because I think, you know, all of the specialists who do procedures were involved with the trial. But I would say there's a larger percentage of vascular surgeons who were involved, and so I'd say they may have a change of their practice. And neurologists may not even get involved at all.  Dr Jones: Right.  Dr Bushnell: That was one of the challenges for getting patients in the trial is that, you know, not all of us see the asymptomatic carotid stenosis, that they tend to get referred to vascular surgery. So, I think maybe in a corner of the practices of vascular surgeons is where you might see the differences.  Dr Jones: Your point about the way the trial was designed or the trials were designed, that intensive medical management is really important, and we have huge gaps in that. In our specialty, it's, you know, we have probably an opportunity in primary care even to address that. And that leads me to my next question. You know, given your perspective and your expertise, what do you think is the biggest practice gap in the care of patients with stroke or with cerebrovascular disease of any kind?  Dr Bushnell: I think by far the biggest gap is transitions of care and access to follow-up in a specialty clinic after discharge and continuous secondary prevention. We only call it secondary prevention because it happened to come after a stroke, but I really feel like we should just focus on prevention and call it that. There are a lot of people who are trying to kind of, get us away from primary versus secondary prevention. And, and Mitch Elkind is phenomenal and had a beautiful chapter weaving in prevention and brain health. So, I highly recommend that people, if they don't read any other chapters of the Continuum to read his, because I think that it's getting to your point about where the gaps are, and I think prevention is the biggest one. I think we could do so much more in models of care to ensure that there is a pathway once patients are discharged. We have no quality metrics. We have no measurement of how well people are doing after they're discharged. We have all of these fancy things and sophisticated acute treatments, but all of those are for naught if somebody goes home and they fall and they have a severe head injury or hip fracture because they weren't properly supervised or they didn't have the help that they needed at home. So, you got me on my soapbox here for a second, but that is definitely what I see as the gap.  Dr Jones: That's an important soapbox, an important gap, and obviously, if it was a simple problem, we could solve it. But it's obviously something that education is a valuable tool for that, and that's part of why we are including so much content in this issue of Continuum. So, if we put that aside as a gap that we would love to close, when you look into the near future or distant future, Dr. Bushnell, and what's the next big thing on the horizon? New interventions, new prevention tools, or something else entirely? What do you think?  Dr Bushnell: There are two things that I would mention. One is sort of the new category of anticoagulants, antithrombotics, the factor XIa inhibitors. We had an amazing presentation of the oceanic stroke trial at the International Stroke Conference, and this is probably going to be a game changer for the arsenal of antithrombotic therapies that we can offer to patients that do not have a reason for anticoagulation. So, they, they don't have atrial fibrillation, for example, or something else that requires anticoagulation. And so, the factor XI, asundexian, is the drug that they used in that trial. The safety profile is pretty amazing. There was very little bleeding complications and a great benefit in those patients with some degree of atherosclerosis, but, you know, of course, not enough to require carotid revascularization, but then also, um, small vessel disease and cryptogenic stroke. I think those are the three categories of patients, and that's a lot of the strokes that we see all benefited from this new drug. So, I think that's gonna be exciting. There, of course, it has to go through the FDA approval process, and so it might take a little bit of time before that's on the market, and we don't know how much it's gonna cost, but I think it is a, a major breakthrough. And of course, there are other similar medications in that category that are coming. And then I think the other thing is the emphasis on brain health and lifestyle factors and the things that we can do to prevent stroke and dementia because they are the same, essentially. Those are really important. And when we have someone in the hospital with a stroke or a TIA in particular, it's a great teaching opportunity for those patients to say, "Hey, here's what you can do to protect your brain." These are things that we always tell people to prevent a stroke, but just think about it as protecting your brain and keeping your brain as healthy as possible.  Dr Jones: That's a great message, and one that you get to share with patients directly. You're joining us today for this interview. You're on stroke service, so you're actively involved in caring for patients with stroke. What in your practice is the most rewarding aspect of caring for these patients? What is it that you find most rewarding?  Dr Bushnell: I've been involved in a clinical trial that has focused on managing blood pressure and also coaching and other aspects of stroke recovery. I think that has probably been the most rewarding aspect of my career. Until I was involved with this trial, I didn't necessarily do intensive blood pressure monitoring, but I'm seeing the benefits of having data from home, what those blood pressures are over a span of time. I see the immediate or intermediate effects of the blood pressure medication changes that I've made, and I see how the patients respond. So, I have to say that this is not part of usual practice, but I think it should be. And I think it's been incredible from the perspective of a neurologist who is really intensively trying to make the patients' lives better. And it's not just what I do, it's what the health coaches do as part of this intervention. And again, very similar to intensive medical management. So, I, I feel like I've been living it in a slightly different setting than in the CREST 2 trials. But there are other trials that have used the intensive medical management as approach as well. But I would say that's the most rewarding. I've seen people who've lost weight, who are physically fit, who are able to get off of blood pressure medications practically by the end of six months, and that's amazing. And then they continue doing it because they see the benefits.  Dr Jones: You've had a front row seat to a lot of that. That's really got to feel rewarding.  Dr Bushnell: It is, absolutely.  Dr Jones: You know, when you put it that way, it makes me want to go home and check my blood pressure, which I haven't done in a while. But I think that's a message to all of our listeners that we do have plenty of opportunity for risk factor optimization and following the evidence that has been generated and is being generated. Huge opportunity, not only at the population level, but I think the, um, individual patient level too. Okay, so now we're back to our Continuum Audio trivia question, and I'll repeat it for our listeners. How was warfarin discovered, and how did it get its name? Dr. Bushnell and I were talking about this earlier, so I'll just go ahead and share the answer. So, in the early 20th century in the U.S. Midwest, there were epidemics of a hemorrhagic disease in cattle, of all places, and this was eventually traced to moldy cattle feed that was made from sweet clover. And in 1940, researchers at the University of Wisconsin discovered that the anticoagulant in the sweet clover was a compound that was later synthesized for therapeutic use in 1954 as warfarin. And the name came from, uh, the support for the research. The research support came from the Wisconsin Alumni Research Foundation, or WARF, and the end of the word came from the underlying compound, which was coumarin. So that was a little bit of trivia that I had never heard. It's not in the issue, everyone, so you're getting something extra here on the podcast. But been using the drug forever. It still has its uses, even though it's become less advantageous than some of the newer agents. But-- And of course, Dr. Bushnell already knew that when I brought it up, but I just thought that was an interesting bit of history. Well, Dr. Bushnell, thank you for joining us. Thank you for such a great conversation about the latest in cerebrovascular disease. I learned a lot today. I learned a lot in reading these wonderful articles. I hope our listeners learned a lot today as well. I'm really grateful for your hard work on the issue, which I think will come in handy for junior readers and subscribers, as well as our more experienced neurologists as well. Sometimes it's hard to keep up with a rapidly changing subspecialty of our field. So, thank you for joining us today.  Dr Bushnell: Thank you for having me. It's been my pleasure.  Dr Jones: Again, today we've been speaking with Dr. Cheryl Bushnell, guest editor of Continuum's most recent issue on cerebrovascular disease. Please check it out, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.

What if the hardest thing you ever face becomes the experience that shapes you into a stronger leader?Steve Garraty shares how a cancer diagnosis at age 18 became one of the most defining experiences of his life. Through a season marked by uncertainty, loss, and physical hardship, he discovered the power of perspective, resilience, and gratitude. Steve reflects on how adversity can shape us, not by avoiding difficult emotions, but by choosing how we respond and what we learn along the way.In our conversation, Steve offers practical insights for navigating challenges with courage and intention. He explores the importance of leaning on support systems, moving beyond a victim mindset, and finding meaning in life's hardest moments. We also discuss how these lessons have influenced the way he leads others, helping him approach leadership with greater empathy, patience, and appreciation. His story reminds us that while adversity is unavoidable, it can become a powerful catalyst for growth, perspective, and purposeful leadership.Key Takeaways:Reframe difficult experiences to build resilience and long-term growth.Crest a support system and lean on others, even when people are disappearing from your life.Acknowledge hardship without becoming trapped by it.Authentically practice gratitude and transform the way you lead others.Make past struggles a source of confidence and strength for future challenges.Resources The Inspire Your Team to Greatness assessment (the Courage Assessment) - In less than 10 minutes, find out where you're empowering and inadvertently kills productivity, and get a custom report that will tell you step by step what you need to have your team get more done. Get it here: https://courageofaleader.com/inspireyourteam/You don't need to have all the answers to lead well. Get your copy of the Clarity Kit for just $17 to learn the five practices to bring more clarity, confidence and courage into your leadership - https://courageofaleader.com/the-clarity-kit/Get your copy of Steve's book, Greatfruit: How Cancer Led to Living a More Fruitful Life - https://a.co/d/0bG6NVcZAbout the Guest:Steve Garraty is a cancer survivor, husband, and father of two beautiful children he was told he would unlikely ever have due to chemotherapy. He has a finance degree from the University of Georgia. He's been in sales and leadership roles for thirty years and has hired, trained, and coached hundreds of people. Steve is passionate about coaching and mentoring others to achieve their goals and accomplish more than they ever imagined. His experience battling cancer led to him being a better parent and leader with a new perspective to live a better, more fruitful, and wonderful life.About the Host:Amy L. Riley is an internationally renowned speaker, author and consultant. She has over 2 decades of experience developing leaders at all levels. Her clients include Cisco Systems, Deloitte and Barclays.As a trusted leadership coach and consultant, Amy has worked with hundreds of leaders one-on-one, and thousands more as part of a group, to fully step into their leadership, create amazing teams and achieve extraordinary results.Amy's most popular keynote speeches are:The Courage of a Leader: The Power of a Leadership LegacyThe Courage of a Leader: Create a Competitive Advantage with Sustainable, Results-Producing Cross-System CollaborationThe Courage of a Leader: Accelerate Trust with Your Team, Customers and CommunityThe Courage of a Leader: How to Build a Happy and Successful Hybrid TeamHer new book is a #1 international best-seller and is entitled, The Courage of a Leader: How to Inspire, Engage and Get Extraordinary Results.http://www.courageofaleader.comhttps://www.linkedin.com/in/amyshooprileyThanks for listening!Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.Do you have some feedback or questions about this episode? Leave a comment in the section below!Subscribe to the podcastIf you would like to get automatic updates of new podcast episodes, you can subscribe to the, podcast on Apple Podcasts or Stitcher. You can also subscribe in your favorite podcast app.Leave us an Apple Podcasts reviewRatings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.Mentioned in this episode:The Inspire Your Team to Greatness Assessment (The Courage Assessment)https://courageofaleader.com/inspireyourteam/

Welcome back to the Audible Bleeding series: Landmark Papers in Vascular Surgery. In this episode, co-hosts John and Dr. Jesse Columbo are joined by our guest, Dr. Caitlin Hicks, to discuss one of the most studied—and most debated—topics in vascular surgery: asymptomatic carotid stenosis.   In this episode, we'll trace that evolution through three pivotal trials: ACAS and ACST-1, which established carotid endarterectomy as the standard of care; and the newly published CREST-2, which challenges us to reconsider everything we thought we knew. Along the way, we'll explore how advances in statin therapy, blood pressure control, and antiplatelet agents have fundamentally changed the natural history of this disease—and what that means for our patients today."   Links to Landmark Papers:  (ACAS) Endarterectomy for Asymptomatic Carotid Artery Stenosis   (ACST-1) 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: a multicentre randomised trial    (CREST-2) Medical Management and Revascularization for Asymptomatic Carotid Stenosis    Guests: Dr. Caitlin Hicks, MD (@CaitlinWHicks); Associate Fellowship Program Director, Vascular Surgery & Endovascular Therapy at Johns Hopkins and Director of Research   Hosts: John Culhane, MD (@JohnCulhaneMD); General Surgery Resident, Abrazo Health Dr. Jesse Columbo, MD; Assistant Professor of The Dartmouth Institute, Geisel School of Medicine, Dartmouth Follow us @audiblebleeding,   Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device. 

Send us Fan MailRolling in the Netherdeep has evolved into Few and Far Between!!Few And Far Between Ep 159Star of the Winter's CrestAs the celebration of Cas and North's vow renewals come to a close, the Favoured Few return to an icy holiday welcome in Rexxentrum.Thanks to Critical Role for helping the community build worlds of adventure!Connect with us via our Linktree!Ron Murphy – DM, @ron88keysRBDMLaphus Prismawing - Jaiden Ramirez, @ffoxtrotXIVOrgoth Skullcrusher - Bill Roper, @billfreakinroperNorth Star Maedrick - Jaime R. Bishop, @steelcladvicarFollow us on Twitter at @SeveredSonsDnD or on Instagram!Join our Discord! Join our Patreon!Now, you can support us through the Buzzsprout website too!Give us a review on Apple Podcasts, Podchaser, Spotify,  GoodPods or on our Twitter page and we'll read it on the air.   Support the show

This week we tell Crest Caps to rest in pieces as Blizzard lifts them a bit early in this opening section of Midnight. Joe gets salacious about addons and new functionality on the PTR. We all hope the Siege of Orgrimmar doesn't last as long as it originally did on any iteration of Classic. Matt throws a bit of a statistical wrench in the works, saying several other raid tiers were actually longer — but it sure didn't feel that way.And next seasonal rollover of Diablo 4 is at the end of June, so you have that long to decide whether you want to purchase all those cool tier 2 World of Warcraft crossover transmogs.Also, we're all laughing at the Krafton CEO, thinking he could get out of paying bonuses for Subnautica 2 by asking ChatGPT. Anyway, the game sold 2 million copies in 12 hours so they're definitely going to be out a ton of cash. Literally couldn't have happened to a better person.If you have a few minutes, please fill out our survey to tell us what you think about the podcast. This data is collected by our podcast host, Acast, and will be used to help us improve the show as well as attract potential sponsors. Your answers are completely anonymous. We appreciate your help!If you enjoy the show, please support us on Patreon, where you can get these episodes early and ad-free! Hosted on Acast. See acast.com/privacy for more information.

PCT - Disappearances Along the Pacific Crest TrailBecome a supporter of this podcast: https://www.spreaker.com/podcast/missing-persons-mysteries--5624803/support.

The party is hounded in interviews by the guards of Chill Stone Keep.DM-DuganPlayers- Audi, Priscilla, Kent & CodyOpening & Closing music by: SunoThank you for another great convention PopCon.

What if essential carotenoid antioxidants you consume today, could protect your vision and cognitive functions now and in the future? In this episode, Professor John Nolan explains how specific carotenoids, lutein, zeaxanthin and meso-zeaxanthin play a critical role in protecting the retina and brain from oxidative stress, a key driver of damage and age-related decline. As a leading researcher in ocular and brain nutrition, he shares ground- breaking insights from clinical trials showing how targeted supplementation can improve visual function and support cognitive performance. Listeners will learn why prevention must begin early, how to identify effective nutritional strategies, and how to take control of long-term eye and brain health to extend their healthspan.Professor John Nolan is a full professor at South East Technological University in Waterford, Ireland, where he holds the Howard Chair in Human Nutrition. He is a nutritional biochemist specializing in the role of carotenoids in vision and cognitive health. As Director of the Nutrition Research Centre Ireland he has led major international clinical trials, including the CREST studies,  published over 100 peer-reviewed scientific papers, and is founder and chair of the International Brain and Ocular Nutrition Conference. His research focuses on targeted nutrition to prevent and manage age-related diseases such as macular degeneration and Alzheimer's disease, advancing evidence-based nutritional strategies to support lifelong eye and brain health.  Episode Timeline  00:00 – Welcome and introduction  04:25 – Origins of carotenoid research and macular degeneration  Early work identifying nutrition as a key modifiable risk factor  09:30 – What carotenoids are and why they matter  Role as antioxidants and "internal sunscreen" for the eye  13:55 – Can macular degeneration be reversed or improved  Distinguishing regeneration, slowing progression, and functional improvement  17:30 – Brain and eye connection  How nutrition may reactivate neural pathways and support cognition  20:27 – Challenging the current medical model  Why prevention must replace late-stage intervention  25:16 – The importance of meso-zeaxanthin  Why some individuals cannot convert nutrients effectively  28:37 – Supplement quality and evidence-based formulations  Risks of unregulated supplements and importance of clinical validation  32:18 – Nutrition, lifestyle, and informed decision-making  Why education and professional guidance are essential  33:21 – Starting early for lifelong protection  "From the cradle to the dance floor" approach to nutrition  35:55 – Declining nutrient density in modern food  Why diet alone may no longer be sufficient  37:18 – Wrap-up and key takeaways  Connect with the research of Prof John Nolan https://profjohnnolan.com Instagram: https://www.instagram.com/profjohnnolan/ LinkedIn: https://www.linkedin.com/in/johnmnolan/ Facebook: https://www.facebook.com/profjohnnolan/ Upcoming Vision for Vision documentary (watch the trailer )   Calls to Action :   Join the Growing Older Living Younger Community   Connect with Dr. Gillian Lockitch at https://www.askdrgill.com/ or email: askdrgill@gmail.com for a personal consult Download Guide to Nature's Colorful Antioxidants 2026  Subscribe to Growing Older Living Younger on your favorite podcast platform and leave a review to help others discover the show.  

As our party reaches Chill Stone Keep, they find defenses high and a not-so-great welcome.DM-DuganPlayers- Kent, Priscilla, Cody & AudiOpening & Closing music by- Suno

Description: The trio talks about Cocodona. This time, it is after Alex has finished the race in under 100 hours! She gives us insight on her adventure as she is still processing the whole experience.Guest: Adam Copeland is the founder of Tantrums, a pack company that disrupted our favorite gear lists list year. While their flagship design, the Crest 6, still holds as one of the highest performing packs, there are new products on the horizon.SUPPORT OUR SPONSORS:Only for Drop listeners, SOAR is giving away $300 in gear and apparel to TWO lucky winners. Their apparel is the best in the industry and their 1-Month Guarantee allows you to shop with total peace of mind – run for 1 month in your new apparel – test it in full – and if you're still not satisfied you can return it, used, for a full refund. No questions asked. Ship worldwide, with all orders delivered direct-to-the-customer without any additional duties or taxes – no post-checkout surprises. Orders over $180 ship FREE. Enter the giveaway here:https://www.soarrunning.com/blogs/news/the-dirt-division-x-soar

Ralph and Denny with minimal help from Blind Freddie find Willow Crest Falls, along with members of The Children of Davey Boy. The question is, is Brandon there too? They're destined to find out. Ralph heads to Willow Crest Falls PD and Denny talks to some rather interesting civilians.

For decades, a tight carotid stenosis felt like a ticking time bomb — a plaque waiting to throw an embolus and cause the next stroke. We were taught that severe narrowing meant surgery, and trials like ACAS and ACST-1 seemed to prove it. But medicine has changed. Statins, antiplatelets, tighter blood pressure control, even PCSK9 and GLP-1 therapies have quietly slashed stroke risk, and now newer data from CREST-2 suggest that for many asymptomatic patients, the knife — or the stent — may not add much at all. So if modern medical therapy works better than ever… who actually benefits from intervention anymore? Today, we unpack the evidence, the controversies, and how to counsel the patient who feels perfectly fine but has high-grade stenosis.Hosts: Carolyn Judge, Andrew Huang, Luciano Delbono, Frank Davis, Robert BeaulieuInstitution: University of Michigan, Department of Surgery, Section of Vascular SurgeryLearning objectives: Describe how modern intensive medical therapy has transformed the natural history of asymptomatic carotid stenosis and explain why contemporary patients experience substantially lower annual stroke risk than those in earlier eras. Interpret and compare the results of landmark trials—including ACAS, ACST-1, and CREST-2—to assess the relative benefits of medical therapy, endarterectomy, and stenting. Apply current evidence and guideline recommendations to patient care by selecting which asymptomatic patients are most likely to benefit from carotid revascularization versus optimized medical therapy alone. References:SVS Guidelines:Brook, R. D., et al. (2022). Society for Vascular Surgery clinical practice guidelines for management of extracranial carotid artery disease. Journal of Vascular Surgery, 75(1), e1–e67. https://doi.org/10.1016/j.jvs.2021.09.031CREST (1)Brott, T. G., Hobson, R. W., Howard, G., et al. (2010). Stenting versus endarterectomy for treatment of carotid-artery stenosis. New England Journal of Medicine, 363(1), 11–23. https://doi.org/10.1056/NEJMoa0912321CREST-2Brott, T. G., Howard, G., Fong, P., et al. (2024). Randomized trial of carotid artery stenting or carotid endarterectomy vs best medical therapy for asymptomatic carotid stenosis: CREST-2 results. [Manuscript in preparation]. ClinicalTrials.gov Identifier: NCT02089217. Retrieved from https://clinicaltrials.gov/ct2/show/NCT02089217ACST-1Halliday, A., Mansfield, A., Marro, J., et al. (2004). Randomised trial of carotid artery surgery for asymptomatic stenosis. Lancet, 363(9420), 1491–1502. https://doi.org/10.1016/S0140-6736(04)16153-1ACST-2Halliday, A., Bulbulia, R., Bonati, L. H., et al. (2021). Carotid artery stenting versus carotid endarterectomy in patients with asymptomatic carotid stenosis (ACST-2): A randomised trial. Lancet, 398(10291), 1065–1073. https://doi.org/10.1016/S0140-6736(21)01980-1ACASExecutive Committee for the Asymptomatic Carotid Atherosclerosis Study. (1995). Endarterectomy for asymptomatic carotid stenosis. JAMA, 273(18), 1421–1428. https://doi.org/10.1001/jama.1995.03520420033036Sponsor URL: https://www.goremedical.com/Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

The cold breaks, and the party continues to ChillStone Keep.DM- DuganPlayers- Cody, Kent, Priscilla & AudiOpening and Closing Music by: Suno

Drs. Sanossian and Saver highlight emerging evidence that routine dental care and oral hygiene may function as actionable, modifiable contributors to stroke prevention beyond traditional vascular risk factors. They also review CREST-2 data showing that carotid revascularization in asymptomatic high-grade carotid stenosis reduces stroke risk, but does not appear to confer additional cognitive benefit over intensive medical therapy alone.

Why does bipolar disorder take years - sometimes decades - to diagnose accurately? And what if artificial intelligence could change that?AI researcher and mood disorder psychiatrist Dr. John-Jose Nunez breaks down the hidden challenges behind bipolar diagnosis and explains how AI could reshape the way we diagnose bipolar disorder. By uncovering new patterns, AI may help doctors see what's been overlooked - earlier and more accurately than ever before. But how close are we to that reality, and what are the limits?(00:00) AI Is Changing How Doctors Diagnose Bipolar (03:16) How Accurate Is AI? Doctors vs AI(06:50) Human-in-the-loop(09:15) Will AI Replace Psychiatrists?Bipolar Explained is a new #talkBD series spotlighting expert perspectives on the history, biology, and management of bipolar disorder.---Dr. John-Jose Nunez is a psychiatrist and clinical researcher whose work bridges psychiatry and computer science, with a focus on using computational approaches including artificial intelligence, machine learning and natural language processing to improve mental health outcomes. He holds an MD and MSc in Computer Science from UBC, and is a Fellow of the Royal College of Physicians of Canada (Psychiatry). Dr. Nunez is an Assistant Professor at the University of British Columbia, a member of the CREST.BD network, and serves as the Associate Medical Director of Supportive Care at BC Cancer.His research aims to use computational methods like artificial intelligence to help patients with mood disorders such as bipolar disorder and depression, and patients experiencing both cancer and mental illness. His thesis work has led to two high-profile publications in JAMA Network Open and Communications Medicine, which garnered international media coverage. His work has been supported by the UBC Institute of Mental Health and the BC Cancer Foundation. More on Dr. Nunez: https://nunezlab.ca

Dangers of the Pacific Crest TrailBecome a supporter of this podcast: https://www.spreaker.com/podcast/missing-persons-mysteries--5624803/support.

As a blizzard starts rolling in, the party is greeted and given safety from an unexpected stranger.DM- DuganPlayers- Cody, Audi, Priscilla & KentOpening/Closing Music: Suno

In this episode of Hurdle, host Emily sits down with professional runner Jess McClain fresh off her monumental performance as the top American finisher at the 2026 Boston Marathon. Recorded in London, where the duo got to run in the upcoming Brooks' upcoming Hyperion Elite 6 and cheer at the 2026 London Marathon, Jess unpacks the physical and mental evolution required to clock a personal best of 2:20:49 on one of the world's most challenging courses. From navigating the "what if" game to handling mid-race mishaps like dropping a fueling bottle, Jess shares a grounded, authentic perspective on what it means to find joy in professional sport. IN THIS EPISODE The Boston Breakthrough: Jess breaks down her strategy for the "Crest of Heartbreak Hill" and how her focus on downhill training and pace changes paid off in the final 10K. Silencing the "What If" Game: A deep dive into the mental shift Jess made during training—moving away from obsessing over variables she couldn’t control and focusing on being 1% better incrementally. Resilience Under Pressure: Jess reflects on the chaos of the Half Marathon Championships where she was directed the wrong way, and how that experience actually built her confidence for the high-stakes friction of Boston. Life Beyond the Miles: An honest conversation about the "other things" that bring joy, including Jess's experience with egg freezing, her thoughts on family planning, and the importance of a supportive partner who sees her greatness. The "My Way" Philosophy: Why Jess decided to stop trying to be a "robotic" athlete and instead leaned into her own unique rhythm, finding that her way is the best way for her. QUOTABLE MOMENTS "I think it’s being okay where you’re at and doing the most that you can day-to-day, week-to-week, to just be 1% better incrementally and not put so much pressure on the big dream." "I spent so much time being told that I shouldn't do anything else... that I'm not dedicated enough. And it's just so not true. You can plan for your future and still have a really kick-ass time running and racing at a high level." "Running's not going to go well all the time. You should be able to tap into other things that bring you joy." "I’ve put my health and the 'fun meter' on the front burner. It feels good to be like, my way is the best way for me, instead of trying to fit myself into so many different molds." SOCIAL@jesstonn@emilyabbate@iheartwomenssports JOIN: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Daily Hurdle IG Channel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ SIGN UP: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Weekly Hurdle Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ASK ME A QUESTION: Email hello@hurdle.us to with your questions! Emily answers them every Friday on the show. Listen to Hurdle with Emily Abbate on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. See omnystudio.com/listener for privacy information.

The TeeBox 4-25-2026 Craig and Eli Broadcast from Crest Cars and Discuss Eli's Visit to the Best Course in Texas and the Latest From the World of Golf 

School enrollment is on the decline and that has major implications for school funding tied to daily attendance. Also, celebrating the City of Trees on Earth Day. Plus, new production of Rashomon opens. Finally, artist performs tonight at the Crest.

durée : 00:03:24 - Entendez-vous l'éco ? - par : Béatrice Cherrier - Quand les prix montent, personne n'est d'accord sur la raison. Depuis 50 ans, chaque crise, qu'elle soit sanitaire, sociale, ou belliqueuse, relance le même affrontement entre économistes. Et la réponse choisit peut tout faire changer. - réalisation : Camille Renard, Pascaline Bonnet, Françoise Le Floch - invités : Béatrice Cherrier Historienne de l'économie, directrice de recherche au CREST et à l'Ecole Polytechnique Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

durée : 00:03:27 - Entendez-vous l'éco ? - par : Béatrice Cherrier - Quand les prix montent, personne n'est d'accord sur la raison. Depuis 50 ans, chaque crise, qu'elle soit sanitaire, sociale, ou belliqueuse, relance le même affrontement entre économistes. Et la réponse choisit peut tout faire changer. - réalisation : Camille Renard, Pascaline Bonnet, Françoise Le Floch - invités : Béatrice Cherrier Historienne de l'économie, directrice de recherche au CREST et à l'Ecole Polytechnique Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Ce jeudi 16 avril, la note du CAE évaluant l'efficacité de l'assurance chômage, la controverse autour de l'élargissement des possibilités de travail le 1er mai, ainsi que le rôle des grands patrons dans la campagne présidentielle de 2027, ont été abordés par Nathalie Janson, professeure d'économie à Neoma Business School, Roland Rathelot, professeur d'économie à l'Institut Polytechnique de Paris et au CREST, membre du CAE, et Olivier Provost, directeur et associé de Rumeur Publique, dans l'émission Les Experts, présentée par Raphaël Legendre sur BFM Business. Retrouvez l'émission du lundi au vendredi et réécoutez la en podcast.

Ce jeudi 16 avril, l'alerte du FMI sur la hausse des dettes publiques qui risque d'être accentuée par la guerre au Moyen-Orient ainsi que le rapport du Conseil d'Analyse Économique sur l'efficacité de l'assurance chômage, ont notamment été abordés par Nathalie Janson, professeure d'économie à Neoma Business School, Roland Rathelot, professeur d'économie à l'Institut Polytechnique de Paris et au CREST, membre du CAE, et Olivier Provost, directeur et associé de Rumeur Publique, dans l'émission Les Experts, présentée par Raphaël Legendre sur BFM Business. Retrouvez l'émission du lundi au vendredi et réécoutez la en podcast.

Ce jeudi 16 avril, Raphaël Legendre a reçu Nathalie Janson, professeure d'économie à Neoma Business School, Roland Rathelot, professeur d'économie à l'Institut Polytechnique de Paris et au CREST, membre du CAE, et Olivier Provost, directeur et associé de Rumeur Publique, dans l'émission Les Experts sur BFM Business. Retrouvez l'émission du lundi au vendredi et réécoutez la en podcast.

durée : 00:02:56 - Le Fil éco - par : Béatrice Cherrier - Selon certains économistes du climat, nos arrière-arrière-petits-enfants ne vaudraient rien. En cause : le taux d'escompte, ce paramètre qui transforme le futur en poussière mathématique. Derrière ce calcul technique se cache l'un des débats les plus politiques de notre temps. - réalisation : Françoise Le Floch - invités : Béatrice Cherrier Historienne de l'économie, directrice de recherche au CREST et à l'Ecole Polytechnique

durée : 00:02:56 - Entendez-vous l'éco ? - par : Béatrice Cherrier - Selon certains économistes du climat, nos arrière-arrière-petits-enfants ne vaudraient rien. En cause : le taux d'escompte, ce paramètre qui transforme le futur en poussière mathématique. Derrière ce calcul technique se cache l'un des débats les plus politiques de notre temps. - réalisation : Camille Renard, Pascaline Bonnet, Françoise Le Floch - invités : Béatrice Cherrier Historienne de l'économie, directrice de recherche au CREST et à l'Ecole Polytechnique Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Clean lumen club! This week, BackTable meets you at the carotid bifurcation to discuss all things carotid angioplasty and stenting. Interventional neuroradiologist and cerebrovascular surgeon Dr. Adnan Siddiqui, Vice Chairman of the University of Buffalo's Department of Neurosurgery, joins host Dr. Sameh Sayfo to discuss the evolution and current state of carotid disease treatment. --- Get the BackTable app https://www.backtable.com/app --- This podcast is supported by Terumohttps://www.terumois.com/ --- Timestamps 00:00 - Introduction02:48 - From Aspirin to Endarterectomy03:47 - Rise of Carotid Stenting06:46 - CREST-2 and CMS Coverage09:57 - Management of Severe Asymptomatic Carotid Stenosis 15:35 - New Stent Designs Explained17:56 - Five Tips for New Operators20:08 - Case Selection Algorithm22:04 - Learning Curve and Mentorship28:27 - What's Next: IVL and Outpatient31:24 - Managing Complications Safely35:05 - Closing and Credits --- More about this episode Dr. Siddiqui details the history of carotid stenosis treatment, charting its path and progression from medical therapy to endarterectomy and modern stenting approaches. He includes how recent trial data and updated CMS reimbursements have influenced practice and generated recent developments such as second generation stent technology. Dr. Siddiqui shares perspectives on patient selection, operator learning curve, complication preparedness, and the importance of structured training and proctoring as technology and techniques continue to improve. The physicians close by overviewing future directions for the carotid space such as IVL and how to approach management of procedural complications. --- Resources Dr. Adnan Siddiqui provider profilehttps://www.ubns.com/physicians/dr-adnan-h-siddiqui/ Carotid Endarterectomy for Asymptomatic Carotid Stenosis: Asymptomatic Carotid Surgery Trial (ACAS)https://www.ahajournals.org/doi/10.1161/01.str.0000141706.50170.a7 Asymptomatic Carotid Surgery Trial (ACST-2)https://www.acc.org/latest-in-cardiology/clinical-trials/2021/08/25/23/24/acst2 Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients (SAPPHIRE trial)https://www.nejm.org/doi/full/10.1056/NEJMoa040127 Medical Management and Revascularization for Asymptomatic Carotid Stenosis (CREST-2 trial) https://www.nejm.org/doi/full/10.1056/NEJMoa2508800 The North American Symptomatic Carotid Endarterectomy Trial (NASCET trial)https://www.ahajournals.org/doi/10.1161/01.str.30.9.1751

durée : 00:03:23 - Le Fil éco - par : Béatrice Cherrier - Alors qu'en France, donner son sang est gratuit, le plasma qui sauve des vies provient à 70 % des États-Unis, où les donneurs sont rémunérés jusqu'à 100 dollars par visite. Depuis soixante ans, économistes et philosophes s'affrontent pour déterminer quel système serait le plus juste. - réalisation : Françoise Le Floch - invités : Béatrice Cherrier Historienne de l'économie, directrice de recherche au CREST et à l'Ecole Polytechnique

This is a classic RISK! episode from January 2014, and it holds up with a particular kind of ferocity. (Content note: sexual assault) Ellie Jackson spent 12 years convincing herself she had moved on from being raped at a college party her freshman year. She'd built a careful system for managing intimacy, or avoiding it, and mostly it held. Then a routine visit to Planned Parenthood, a persistent social worker, and an accidental encounter with a Crest commercial undid all of it at once. (Content note: physical abuse, domestic violence, child abuse) Liz Stewart grew up with a sociopathic father and a paranoid schizophrenic mother who once pinned her to the floor to perform a homemade exorcism. She had boxed for eight years and never once hit back. Until she did. Two stories. Both women fought back. Full episode details and music credits at risk-show.com/podcast/fighting-back-cre515  Support RISK! & Get Involved

Welcome to the Oncology Brothers podcast! In this episode, we dived into the evolving treatment algorithms for bladder cancer following the latest data presented at GU ASCO 2026. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explore: The role of immunotherapy in non-muscle invasive bladder cancer, highlighting the recent positive trials: CREST with Sasanlimab and POTOMAC with Durvalumab. Insights on the current standard of care and the implications of combining BCG with immunotherapy. The shift in treatment strategies for muscle-invasive bladder cancer, including the new standard of care with the EV-Pembro combination and its impact on pathologic complete response rates. The challenges and considerations in managing side effects associated with new therapies, as well as the importance of patient selection and coordination between urologists and medical oncologists. The emerging role of ctDNA in guiding treatment decisions and the ongoing discussions around the sequencing of therapies in refractory settings. Hope you enjoy this informative discussion that aims to keep you up to date in the world of cancer treatment, here focusing on bladder cancer. Subscribe to our channel for more episodes and discussions on the latest in oncology! #BladderCancer, #NMIBC, #MIBC, #Immunotherapy, #GU26, #OncologyBrothers

The Boys are back today breaking down all the betting action in the sports world. To start the guys break down all the action they missed. As always they give their best bets for the day in MLB, NBA, CBB, NHL, Footy, and more.

Pastor Scott is joined by Sabryna Azar as she shares how the Lord has been working in her life and showing his faithfulness in unique ways as she has sought to serve children at risk of entering the foster system.

This week in True Crime Today's Week in Review, the Walk the Dog letter is not treated as a news story. It is treated as an exhibit. Tony Brueski examines the six-page jailhouse letter attributed to Kouri Richins with the specificity the legal record demands — each section analyzed not for shock value but for evidentiary function. The Ronney witness narrative and what it establishes about alleged tampering intent. The airport drug story as a constructed defense mechanism rather than authentic recollection. The GMA media coordination and what it implies about narrative management. The Lotto suppression request. The Katie ask. The Crest whitening strips passage, which read carefully speaks directly to state of mind.That legal analysis extends into psychological territory with direct implications for how juries evaluate defendants. Psychotherapist Shavaun Scott and former FBI Counterintelligence Behavioral Analysis Chief Robin Dreeke examine the documented background of Kouri Richins and what behavioral research tells us about the development of deceptive conduct over time. Whether a pattern of behavior predates the alleged crime is not an academic question — it is often precisely what the government uses to build a consciousness of guilt argument.This is the legal and analytical work this case requires. Kouri Richins has pleaded not guilty and is presumed innocent until proven guilty in a court of law.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #KouriRichinsTrial #TrueCrimeToday #JailhouseLetter #WitnessTampering #ConsciousnessOfGuilt #EricRichins #MurderTrial #LegalAnalysis #WalkTheDog

This week in Hidden Killers' Week in Review, the Walk the Dog letter gets treated the way the legal record demands — as evidence. Tony Brueski breaks it down section by section: the Ronney narrative and the degree of scripted witness instruction embedded in it, the airport drug story constructed as a pre-emptive defense mechanism rather than genuine recollection, the GMA media coordination complete with assigned speaking lines, the Lotto suppression request, the Katie section and how casually it's framed, and the Crest whitening strips passage — which, when read closely, functions as one of the most revealing details in the entire document.Because a letter this calculated doesn't come from nowhere, the conversation also examines the documented instability in Kouri Richins' background alongside psychotherapist Shavaun Scott and former FBI Counterintelligence Behavioral Analysis Chief Robin Dreeke — and asks what, if anything, it explains about the alleged behavior now in front of a jury. The forensic behavioral research on children exposed to a parent's alleged criminal conduct at this level of public scrutiny is also addressed directly.What the evidence actually says. What the people qualified to analyze it actually think. Kouri Richins has pleaded not guilty and is presumed innocent until proven guilty in a court of law.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #KouriRichinsTrial #JailhouseLetter #WalkTheDog #WitnessTampering #EricRichins #TrueCrimeEvidence #HiddenKillers #ConsciousnessOfGuilt #TrueCrime

Eric Richins suspected something was wrong. His friends knew the marriage was in trouble. His sister hired a private investigator. He'd already met quietly with a divorce attorney. And he still ended up dead. This Hidden Killers Week In Review pulls back from the courtroom to examine what this case forces us to reckon with—and breaks down the document that may decide it.Defense attorney Bob Motta and former FBI behavioral analyst Robin Dreeke go at the bigger picture. What does a case like this tell us about how alleged domestic poisonings operate—and why they're almost invisible until they're already done? What separates a financial motive from just a circumstance, and how much weight should a jury actually give debt and insurance in a murder case? If Kouri Richins is acquitted, what does that verdict tell us about the evidentiary bar for this entire category of crime?Then Tony Brueski takes the Walk the Dog letter apart page by page. The six-page jailhouse document deserves more than headlines—it deserves explanation. What is each scheme designed to accomplish? How is the witness narrative for Ronney constructed? Why does the airport drug story function as a pre-built defense mechanism rather than a memory?The GMA coordination reads like stage directions. The Lotto section shows what's being suppressed. The Katie section reveals what's being requested—and how casually. And the Crest whitening strips request tells you more about state of mind than almost anything else in the letter.The question that cuts deepest: is the case the public has followed for three years the same case the jury is actually being asked to decide?Two experts. No easy answers.Kouri Richins has pleaded not guilty.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #EricRichins #TrueCrimeToday #WalkTheDogLetter #DomesticPoisoning #BobMotta #RobinDreeke #KouriRichinsTrial #JailhouseLetter #TrueCrime

The Walk the Dog letter has been in headlines. But headlines don't explain it. This Hidden Killers Week In Review takes the full six-page jailhouse letter written by Kouri Richins and breaks it down the way it deserves—not as shocking bullet points, but as a document that prosecutors intend to use as evidence of consciousness of guilt.Tony Brueski explains exactly how the witness narrative is constructed. The level of scripted detail for Ronney. The instruction to meet in person rather than by phone. The use of legal language followed immediately by "LOL"—and why all of that matters beyond the surface content. The airport drug story functions as a pre-built defense mechanism, not a memory. The GMA coordination reads like stage directions when you say the assigned lines out loud.The Lotto section reveals what's being suppressed and why. The Katie section shows what's actually being requested—and how casually it's framed. And the Crest whitening strips request tells you more about Kouri Richins' state of mind than almost anything else in the letter.Defense attorney Bob Motta and former FBI behavioral analyst Robin Dreeke pull back to examine the bigger picture. Eric Richins suspected something was wrong. His friends knew. His sister hired a PI. He'd met with a divorce attorney. He still ended up dead. What does a case like this tell us about how alleged domestic poisonings operate—and why they're almost invisible until they're done?What separates a financial motive from just a circumstance? How much weight should a jury give debt and insurance in a murder case? And the question that cuts deepest: is the case the public has followed for three years the same case the jury is actually being asked to decide?Kouri Richins has pleaded not guilty.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #EricRichins #WalkTheDogLetter #JailhouseLetter #BobMotta #RobinDreeke #WitnessTampering #KouriRichinsTrial #HiddenKillers #TrueCrime

The Walk the Dog letter has been in headlines. But headlines don't explain it. This episode does.Tony Brueski at True Crime Today takes the full six-page jailhouse letter written by Kouri Richins and breaks it down the way it deserves to be broken down — not as a collection of shocking bullet points, but as a document. What does each page actually say? What is each scheme actually designed to accomplish? And what does understanding all of it together tell us about how prosecutors intend to use it?Start with Ronney. Tony explains exactly how the witness narrative is constructed in the letter — the level of scripted detail, the instruction to meet in person rather than by phone, the use of legal language followed immediately by "LOL" — and why all of that matters beyond just the surface content. Move to the airport drug story and understand how it functions as a pre-built defense mechanism, not a memory. Follow the GMA coordination through to what it actually looks like when you read the assigned lines out loud.Then understand the Lotto section — what's being suppressed and why. Sit with the Katie section long enough to understand what is actually being requested and how casually it's framed. And close on the Crest whitening strips, which Tony argues tells you more about Kouri Richins' state of mind than almost anything else in the letter.This is the explanation the case deserves. Kouri Richins has pleaded not guilty and is presumed innocent until proven guilty in a court of law.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #TrueCrimeToday #WalkTheDog #KouriRichinsTrial #JailhouseLetter #EricRichins #TrueCrime #MurderTrial #WitnessTampering #ConsciousnessOfGuilt